1. Beral V, Hermon C, Munoz N, et al. Cervical cancer. Cancer Surv 1994;19Y20:265-285.
2. Schiffman M, Wentzensen N, Wacholder S, et al. Human papillomavirus testing in the prevention of cervical cancer. J Natl Cancer Inst 2011;103:368-383.
3. Li N, Franceschi S, Howell-Jones R, et al. Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: variation by geographical region, histological type and year of publication. Int J Cancer 2011;128:927-935.
4. Ogilvie GS, Patrick DM, Schulzer M, et al. Diagnostic accuracy of self collected vaginal specimens for human papillomavirus compared to clinician collected human papillomavirus specimens: a meta-analysis. Sex Transm Infect 2005;81:207-212.
5. Petignat P, Faltin DL, Bruchim I, et al. Are self-collected samples comparable to physician-collected cervical specimens for human papillomavirus DNA testing? A systematic review and meta-analysis. Gynecol Oncol 2007;105:530-535.
6. De Alba I, Anton-Culver H, Hubbell FA, et al. Self-sampling for human papillomavirus in a community setting: feasibility in Hispanic women. Cancer Epidemiol Biomarkers Prev 2008;17:2163-2168.
7. Wright TCJr, Denny L, Kuhn L, et al. HPV DNA testing of self-collected vaginal samples compared with cytologic screening to detect cervical cancer. JAMA 2000;283:81-86.
8. Sherman ME, Lorincz AT, Scott DR, et al. Baseline cytology, human papillomavirus testing, and risk for cervical neoplasia: a 10-year cohort analysis. J Natl Cancer Inst 2003;95:46-52.
9. Goldie SJ, Kuhn L, Denny L, et al. Policy analysis of cervical cancer screening strategies in low-resource settings: clinical beneﬁts and cost-effectiveness. JAMA 2001;285:3107-3115.
10. Khan MJ, Castle PE, Lorincz AT, et al. The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-speciﬁc HPV testing in clinical practice. J Natl Cancer Inst 2005;97:1072-1079.
13. Byrd TL, Chavez R, Wilson KM. Barriers and facilitators of cervical cancer screening among Hispanic women. Ethn Dis 2007;17:129-134.
14. Gök M, van Kemenade FJ, Heideman DA, et al. Experience with high-risk human papillomavirus testing on vaginal brush-based self-samples of non effectiveness. JAMA 2001;285:3107-3115.
15. Virtanen A, Anttila A, Luostarinen T, et al. Self-sampling versus reminder letter: effects on cervical cancer screening attendance and coverage in Finland. Int J Cancer 2011;128:2681-2687.
16. Gök M, Heideman DA, van Kemenade FJ, et al. HPV testing on self collected cervicovaginal lavage specimens as screening method for women who do not attend cervical screening: cohort study. BMJ 2010;340:c1040.
17. Szarewski A, Cadman L,Mesher D, et al. HPV self-sampling as an alternative strategy in non-attenders for cervical screening-a randomised controlled trial. Br J Cancer 2011;104:915-920.
18. Giorgi Rossi P, Marsili LM, Camilloni L, et al. The effect of self-sampled HPV testing on participation to cervical cancer screening in Italy: a randomized controlled trial (ISRCTN96071600). Br J Cancer 2011;104:248-254.
19. Wikström I, Lindell M, Sanner K, et al. Self-sampling and HPV testing or ordinary Pap-smear in women not regularly attending screening: a randomised study. Br J Cancer 2011;105:337-339.
20. Sanner K, Wikström I, Strand A, et al. Self-sampling of the vaginal ﬂuid at home combined with high-risk HPV testing. Br J Cancer 2009;101: 871-874.
21. Bais AG, van Kemenade FJ, Berkhof J, et al. Human papillomavirus testing on self-sampled cervicovaginal brushes: an effective alternative to protect nonresponders in cervical screening programs. Int J Cancer 2007;120:1505-1510.
22. Holanda F, Castelo A, Veras TM, et al. Primary screening for cervical cancer through self sampling. Int J Gynaecol Obstet 2006;95:179-184.
23. Qiao YL, Sellors JW, Eder PS, et al. A new HPV-DNA test for cervical- cancer screening in developing regions: a cross-sectional study of clinical accuracy in rural China. Lancet Oncol 2008;9:929-936.
24. Lazcano-Ponce E, Lorincz AT, Cruz-Valdez A, et al. Self-collection of vaginal specimens for human papillomavirus testing in cervical cancer prevention (MARCH): a community-based randomised controlled trial. Lancet 2011;378:1868-1873.
25. Krueger R, Casey M. Focus Groups: A Practical Guide for Applied Research, 3rd ed, Thousand Oaks, CA: Sage Publications, 2000.
26. King N. Using Templates in the Thematic Analysis of Text. Essential Guide to Qualitative Methods in Organizational Research, London, UK: Sage Publications, 2004.
27. Suarez L, Pulley L. Comparing acculturation scales and their relationship to cancer screening among older Mexican-American women. J Natl Cancer Inst Monogr 1995:41-47.
28. Fernandez-Esquer ME, Espinoza P, Ramirez AG, et al. Repeated Pap smear screening among Mexican-American women. Health Educ Res 2003;18:477-487.
29. Fernandez-Esquer ME, Cardenas-Turanzas M. Cervical cancer screening among Latinas recently immigrated to the United States. Prev Med 2004;38:529-535.
30. Adams EK, Breen N, Joski PJ. Impact of the National Breast and Cervical Cancer Early Detection Program on mammography and Pap test utilization among white, Hispanic, and African American women: 1996Y2000. Cancer 2007;109:348-358.
31. Wallace D, Hunter J, Papenfuss M, et al. Pap smear screening among women >/=40 years residing at the United States-Mexico border. Health Care Women Int 2007;28:799-816.
32. Byrd TL, Peterson SK, Chavez R, et al. Cervical cancer screening beliefs among young Hispanic women. Prev Med 2004;38:192-197.
33. Swan J, Breen N, Coates RJ, et al. Progress in cancer screening practices in the United States: results from the 2000 National Health Interview Survey. Cancer 2003;97:1528-1540.
34. McPhee SJ, Bird JA, Davis T, et al. Barriers to breast and cervical cancer screening among Vietnamese-American women.Am J Prev Med 1997;13: 205-213.
35. Hislop T, Deschamps M, Teh C, et al. Facilitators and barriers to cervical cancer screening among Chinese Canadian women. Can J Public Health 2003;94:68-73.
36. Lee MC. Knowledge, barriers, and motivators related to cervical cancer screening among Korean-American women. A focus group approach. Cancer Nurs 2000;23:168-175.
37. Kahn JA, Bernstein DI, Rosenthal SL, et al. Acceptability of human papillomavirus self testing in female adolescents. Sex Transm Infect 2005;81:408-414.
38. Anhang R, Nelson JA, Telerant R, et al. Acceptability of self-collection of specimens for HPV DNA testing in an urban population. J Womens Health (Larchmt) 2005;14:721-728.
39. Waller J, McCaffery K, Forrest S, et al. Acceptability of unsupervised HPV self-sampling using written instructions. J Med Screen 2006;13:208-213.
40. Quincy BL, Turbow DJ, Dabinett LN. Acceptability of self-collected human papillomavirus specimens as a primary screen for cervical cancer. J Obstet Gynaecol 2012;32:87-91.
41. Mitchell S, Ogilvie G, Steinberg M, et al. Assessing women’s willingness to collect their own cervical samples for HPV testing as part of the ASPIRE cervical cancer screening project in Uganda. Int J Gynaecol Obstet 2011;114:111-115.
42. Solomon D, Breen N, McNeel T. Cervical cancer screening rates in the United States and the potential impact of implementation of screening guidelines. CA Cancer J Clin 2007;57:105-111.
43. Saraiya M, Berkowitz Z, Yabroff KR, et al. Cervical cancer screening with both human papillomavirus and Papanicolaou testing vs Papanicolaou testing alone: what screening intervals are physicians recommending?. Arch Intern Med 2010;170:977-985.
44. Howard MLytwyn A, Lohfeld L, et al. Barriers to acceptance of self-sampling for human papillomavirus across ethnolinguistic groups of women. Can J Public Health 2009;100:365-369.
45. Forrest S, McCaffery K, Waller J, et al. Attitudes to self-sampling for HPV among Indian, Pakistani, African-Caribbean and white British women in Manchester, UK. J Med Screen 2004;11:85-88.